International Linked Clinical Trials (iLCT)

22 results.

June 8, 2018 From discovery to medicine
Part two: Before a new medication can be used in patients, it must go through a gauntlet of tests to ensure it is safe and effective

In the second installment in our multi-part series on how a new medication moves from the lab to the doctor’s office, we take a look…

August 3, 2017 Promising results from study of type 2 diabetes drug in treatment of Parkinson’s disease

Evidence continues to mount that a newer class of anti-diabetic drugs called incretin mimetics, or glucagon-like peptide-1 receptor agonists, could slow…

September 8, 2016 Diabetes drug focus of new clinical trial for Parkinson’s disease

HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…

July 12, 2016 Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust collaborate to assess the clinical use and development of nilotinib in Parkinson’s disease

Note: To read the commentary published in the Journal of Parkinson's Disease click here. Investigators will focus on safety for long-term use in non-cancer…

February 22, 2016 Promising respiratory drug focus of new clinical trial for Parkinson’s disease

GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus…

September 23, 2014 Van Andel Research Institute joins The Cure Parkinson’s Trust to accelerate development of new Parkinson’s disease treatments

Grand Rapids, Mich. (Sept. 23, 2014) – Van Andel Research Institute (VARI) has partnered with UK-based research charity The Cure Parkinson’s Trust on an initiative to…